The Effects of Virtual Natural Environments on Residents' Health

November 13, 2025 updated by: Taipei Medical University

The Effects of Virtual Natural Environments in Improving Older Residents' Physical and Psychological Health in Long-term Care Facilities

This randomized controlled trial aims to explore the impact of virtual natural environments on the mental and physical health of older adults in long-term care facilities. A total of 120 participants will be divided into three groups: a virtual reality (VR) group, a tablet screen-based natural environments group (Tab), and a control group (C) receiving routine care. The intervention involves viewing virtual natural landscapes for 10 minutes, three times a week, over eight weeks. The study will evaluate the effectiveness of these virtual environments in enhancing the quality of life for elderly residents, with data collection occurring at multiple time points. Additionally, qualitative interviews will be conducted with VR group participants to capture their experiences and emotional responses.

Study Overview

Detailed Description

This study investigates whether virtual natural environments can improve the mental and physical health of older adults living in long-term care facilities. The trial will involve 120 participants randomly assigned to one of three groups: a virtual reality (VR) group, a tablet screen-based natural environments group (Tab), and a control group (C) receiving routine care. The intervention consists of viewing virtual natural landscapes for 10 minutes, three times a week, over an eight-week period.

The study's primary focus is to assess the impact of these virtual environments on participants' overall well-being and quality of life. Data will be collected at multiple stages throughout the intervention, and statistical analysis will be conducted to determine the effectiveness of the virtual nature sessions. In addition to the quantitative analysis, qualitative interviews will be carried out with participants in the VR group to gather deeper insights into their experiences and the emotional benefits they may derive from the intervention. These interviews will provide valuable context to the quantitative findings, helping to understand the broader implications of using virtual natural environments in long-term care settings.

Study Type

Interventional

Enrollment (Actual)

101

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Taiwan
      • Taipei, Taiwan, Taiwan, 11031
        • Taipei Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age 60 years or older
  • Residency in a long-term care institution for more than 1 month
  • Clear consciousness

Exclusion Criteria:

  • Blindness
  • Presence of an infectious disease
  • Inability to wear glasses

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Virtual Reality Group (VR)
Participants in this group will engage with immersive virtual reality (VR) natural landscapes.
Participants will view immersive virtual natural landscapes using virtual reality (VR) headsets for 10 minutes, three times a week, over eight weeks. They will choose the natural landscapes they wish to visit and admire, allowing for personalized engagement with the virtual environment.
Active Comparator: Tablet Screen Group (Tab)
Participants in this group will view natural landscapes on a tablet screen.
Participants will watch immersive virtual natural landscapes on a tablet screen for 10 minutes, three times a week, over eight weeks. Participants can select the natural landscapes they prefer to view during the sessions, providing a personalized experience.
No Intervention: Control Group (C)
Participants in this group will continue their usual care routine without additional exposure to virtual or screen-based natural environments.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Level of Relaxation
Time Frame: Immediately before and immediately after each intervention session
This study will use the Visual Analogue Scale (VAS) for relaxation.The VAS is a 0-100 mm scale, with 0 mm indicating no relaxation and 100 mm indicating a high level of relaxation.
Immediately before and immediately after each intervention session
Temperature
Time Frame: Immediately before and immediately after each intervention session.
Measurement of body temperature to monitor physiological changes. Unit of Measure: Degrees Celsius (°C)
Immediately before and immediately after each intervention session.
Heart Rate
Time Frame: Immediately before and immediately after each intervention session.
Measurement of heart rate to monitor physiological changes. Unit of Measure: Beats per minute (bpm)
Immediately before and immediately after each intervention session.
Respiration Rate
Time Frame: Immediately before and immediately after each intervention session.
Measurement of respiration rate to monitor physiological changes. Unit of Measure: Breaths per minute
Immediately before and immediately after each intervention session.
Blood Pressure
Time Frame: Immediately before and immediately after each intervention session.
Measurement of blood pressure to monitor physiological changes. Unit of Measure: Millimeters of mercury (mmHg)
Immediately before and immediately after each intervention session.
Well-being
Time Frame: Baseline (pre-intervention), mid-intervention (week 4), end of intervention (week 8), and follow-up at one month post-intervention (week 12)
This study will use the 10-item version of the Chinese Happiness Inventory (CHI), adapted from the Oxford Happiness Inventory. The scale has 10 items scored on a 4-point Likert scale, ranging from 0 (minimum) to 3 (maximum), with a total score between 0 and 30. Higher scores indicate greater happiness among elderly residents.
Baseline (pre-intervention), mid-intervention (week 4), end of intervention (week 8), and follow-up at one month post-intervention (week 12)
Heart Rate Variability (HRV)
Time Frame: Immediately before and immediately after each intervention session
HRV refers to the variation in the intervals between heartbeats (RR interval) and is influenced by both the sympathetic and parasympathetic nervous systems. This study will use the VIPcare Plus Smart Band to collect HRV data, including low frequency (LF) and high frequency (HF) power values, as well as the LF/HF ratio, to assess autonomic nervous system balance
Immediately before and immediately after each intervention session
Emotion
Time Frame: Baseline (pre-intervention), mid-intervention (week 4), end of intervention (week 8), and follow-up at one month post-intervention (week 12)
This study will use the Positive and Negative Emotion Scale to measure the emotional states of residents. The scale has 12 items divided into two subscales: the first 6 items assess positive emotions, and the last 6 items assess negative emotions. It is scored on a 5-point Likert scale. The total score for the Positive Emotion Subscale ranges from 6 to 30, where higher scores indicate stronger positive emotions. The Negative Emotion Subscale has the same score range.
Baseline (pre-intervention), mid-intervention (week 4), end of intervention (week 8), and follow-up at one month post-intervention (week 12)
Affect
Time Frame: Baseline (pre-intervention), mid-intervention (week 4), end of intervention (week 8), and follow-up at one month post-intervention (week 12)
The Positive and Negative Affect Schedule (PANAS) will be used to measure emotional states. The scale has 20 items, with 10 items each for positive and negative affect. Higher scores on the Positive Affect Subscale (10-50) indicate higher positive affect, and higher scores on the Negative Affect Subscale (10-50) indicate higher negative affect.
Baseline (pre-intervention), mid-intervention (week 4), end of intervention (week 8), and follow-up at one month post-intervention (week 12)
Anxiety
Time Frame: Baseline (pre-intervention), mid-intervention (week 4), end of intervention (week 8), and follow-up at one month post-intervention (week 12)
The Geriatric Anxiety Inventory (GAI) will be used to assess anxiety levels in elderly residents.The inventory has 20 items, with scores of 0 (no symptoms) or 1 (symptoms present), yielding a total score between 0 and 20. Higher scores indicate higher levels of anxiety.
Baseline (pre-intervention), mid-intervention (week 4), end of intervention (week 8), and follow-up at one month post-intervention (week 12)
Perceived Stress
Time Frame: Baseline (pre-intervention), mid-intervention (week 4), end of intervention (week 8), and follow-up at one month post-intervention (week 12)
The Perceived Stress Scale (PSS-10) will be used to measure the residents perceived stress levels.
Baseline (pre-intervention), mid-intervention (week 4), end of intervention (week 8), and follow-up at one month post-intervention (week 12)
Depression
Time Frame: Baseline (pre-intervention), mid-intervention (week 4), end of intervention (week 8), and follow-up at one month post-intervention (week 12)
The Geriatric Depression Scale-Short Form (GDS-SF) will be used to measure depression levels. The scale consists of 15 items with yes/no responses. The total score ranges from 0 to 15, with higher scores indicating more severe depression.
Baseline (pre-intervention), mid-intervention (week 4), end of intervention (week 8), and follow-up at one month post-intervention (week 12)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yeu-Hui Chuang, Taipei Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 16, 2024

Primary Completion (Actual)

October 7, 2025

Study Completion (Actual)

October 7, 2025

Study Registration Dates

First Submitted

August 29, 2024

First Submitted That Met QC Criteria

September 3, 2024

First Posted (Actual)

September 19, 2024

Study Record Updates

Last Update Posted (Actual)

November 17, 2025

Last Update Submitted That Met QC Criteria

November 13, 2025

Last Verified

October 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There is no plan to share individual participant data from this study.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychological Health

Clinical Trials on Virtual Reality Natural Landscape Exposure

Subscribe